Balmoral’s Bug South Deposit Continues to Deliver Broad Gold Intercepts

VANCOUVER, British Columbia, July 12, 2017 -- Balmoral Resources Ltd. (“Balmoral” or the “Company”) (TSX:BAR) (OTCQX:BALMF) today released the final drill results from the Company’s spring drill program on its Detour Gold Trend Project in Quebec. A series of holes testing the Bug South gold deposit (see Figure 1), on its wholly owned Martiniere Property successfully extended the Bug South deposit to a vertical depth of approximately 385 metres with a broad intercept of 14.28 metres grading 3.51 g/t gold, including a very high grade interval of 0.46 metres grading 66.60 g/t gold (see Figure 2). The Bug South deposit remains open down-plunge to the south-southeast. Drilling is currently focused on additional expansion of the deposit to depth.

Category: Silver / Gold

Published: 12 July 2017

Written by Editor

EBITDA increases 181% in the quarter, exceeding $2.8 million

Cash costs to produce dried cannabis per gram decreases 35% from prior quarter

LEAMINGTON, ONTARIO--(July 12, 2017) - Aphria Inc. ("Aphria" or the "Company") (TSX:APH)(OTCQB:APHQF) today reported its results, for the four quarter and year ended May 31, 2017. All amounts are expressed in Canadian dollars.

Category: Medical Marijuana

Published: 12 July 2017

Written by Editor

TSX Financial Results Up on News

Myomo, Inc. Introduces Center of Excellence Program

Nationwide Roster of Top O&P Practices Supports MyoPro® Powered Orthosis

Myomo®, Inc. (NYSE MKT: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced the launch of its Center of Excellence (CoE) program, which recognizes top orthotics and prosthetics (“O&P”) practices in the U.S. that support its MyoPro® line of powered orthoses. MyoPro is the only lightweight wearable device that can restore function in the paralyzed or weakened arms and hands of individuals who have suffered a stroke, spinal cord or nerve injury, or other neuromuscular disability. With the orthosis, a paralyzed individual can perform activities of daily living including feeding themselves, carrying objects and doing household tasks, and many are able to return to work.

Category: Medical Devices

Published: 12 July 2017

Written by Editor

AMEX tsxvup on news

OpGen Acuitas ® MDRO Gene Test Approved by NY State Department of Health

GAITHERSBURG, Md., July 12, 2017 -- OpGen, Inc. (NASDAQ:OPGN) announced today that the New York State Department of Health (NYSDOH) has approved the Acuitas® MDRO Gene Test for use by physicians and healthcare providers in the state. The approval of OpGen’s CLIA laboratory to perform testing in New York State includes approval for the complete OpGen MDRO testing workflow, including MDRO gene testing on perianal swabs and clinical isolates. The NYSDOH regulates and oversees clinical diagnostic laboratories that test specimens from the state residents.

The Acuitas MDRO Gene Test is a CLIA lab-based test able to provide information regarding the presence of ten MDRO resistance genes from one patient specimen. The ten drug-resistant genes identified by our Acuitas MDRO Gene Test are associated with CRE, ESBL and VRE organisms, and are gastrointestinal organisms frequently associated with antibiotic-resistant infections. The test results can be used by healthcare providers to identify patients colonized with organisms expressing the drug-resistant genes or who are actively infected.

Category: Diagnostic / Testing

Published: 12 July 2017

Written by Editor

Nasdaq Up on News Project Update

Read more: OpGen Inc ( OPGN )

Point Roberts, WA, July 12, 2017 - Investorideas.com, a global news source covering leading sectors including mining stocks issues a follow up to the recent Pershing Gold Corporation (NASDAQ:PGLC), (TSX:PGLC), (FWB:7PG1) Preliminary Feasibility Study (PFS) on the company’s Relief Canyon Mine.

Read this news in full at http://www.investorideas.com/CO/PGLC/news/2017/07121PreliminaryFeasibilityStudy.asp

Highlights from the PFS include a pre-tax net present value ("NPV") of $144.6 million, an internal rate of return ("IRR") of 89% and Net Cash Flow of $192.7 million. This NPV, IRR and Net Cash Flow assume pre-tax economics using $1,250.00 per ounce ("/oz") of gold ("Au"), $16.75/oz of silver ("Ag") and a 5% discount rate.

Recent research reports and interviews with management give investors a closer look at the economics and the bottom line.

Category: Submitted Articles

Published: 12 July 2017

Written by Investor Ideas

Page 7 of 2849

Balmoral Resources ( BAR )

Balmoral’s Bug South Deposit Continues to Deliver Broad Gold Intercepts

Aphria Inc ( APH )

EBITDA increases 181% in the quarter, exceeding $2.8 million

Myomo Inc ( MYO )

Myomo, Inc. Introduces Center of Excellence Program

OpGen Inc ( OPGN )

OpGen Acuitas ® MDRO Gene Test Approved by NY State Department of Health

Follow up to Pershing Gold Corporation’s ( $PGLC) PreliminaryFeasibility Study (PFS) on Relief Canyon Mine; The Bottom Line

Videos / Webinars

Photos / Charts

Stockjunction Members